At Momenta, we don’t see impossible as a hindrance. It’s what drives us to develop novel therapies for patients with rare diseases.

Supporting Our Patients and Our Communities During the COVID-19 Outbreak:

Momenta is dedicated to the well-being of patients around the world and to pioneering therapies for complex diseases few are willing to tackle. Our team truly is driven by impossible. We all recognize our responsibility to do what we can to help those in need due to the COVID-19 outbreak. We are proactively supporting our employees during this extraordinary time and are working closely with our clinical trial site teams to care for the patients in our clinical trials.

The impact of this pandemic on our healthcare system, communities, and families is extensive. We are donating to local organizations, supporting the medical community with personal protective equipment and have donated hand sanitizers to our local police department. We are also starting an employee charitable fund to support organizations and communities in need. We encourage others to do what they can during this public health crisis.

Crazy for doing good, we are committed to ensuring the health and safety of our colleagues, our patients and their caregivers, and to helping end the spread of this disease.

Read our press release

At Momenta, we don’t stop at impossible.

We’re challengers. Difference makers. We push the limits and are willing to take risks — because that’s where the chance to make real impact lives.

Working at Momenta

We take on the challenges that few are brave enough to tackle.

Explore Careers

Our Focus



Generalized Myasthenia Gravis (gMG)

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)



Idiopathic Thrombocytopenic Purpura (ITP)

Warm Autoimmune Hemolytic Anemia (wAIHA)